MEAGAN TURNER: Open Payments
NPI 1972757557 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 59 payments from 27 companies in 2025. Trend: 2023 $1,339 · 2024 $1,102 · 2025 $1,405
Food & beverage: $1,197Education: $208
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $178 |
| Incyte Corporation | 8 | $155 |
| Gilead Sciences, Inc. | 4 | $134 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| GENZYME CORPORATION | 3 | $77 |
| JAZZ PHARMACEUTICALS INC. | 2 | $58 |
| PFIZER INC. | 3 | $57 |
| TerSera Therapeutics LLC | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
Products named: Trodelvy, ENHERTU, CALQUENCE, SCEMBLIX, JAKAFI, ZEPZELCA, KISQALI, Zoladex.
Industry payments across IL — which companies pay providers there.
